What is Damiva?
Damiva operates at the intersection of health and beauty, specializing in 100% natural, water-free, and chemical-free skincare products tailored specifically for women. By prioritizing uncompromised ingredients, the company has carved out a niche in the wellness market, offering a specialized product suite that includes vaginal moisturizers, labial balms, and premium hand lotions. The firm's core philosophy centers on long-term safety and efficacy, empowering women to prioritize their well-being through products that avoid synthetic additives. This focus on clean-label innovation positions Damiva as a disruptive force in the personal care landscape, appealing to a demographic that increasingly demands transparency and safety in their daily health routines.
How much funding has Damiva raised?
Damiva has raised a total of $1.2M across 1 funding round:
Angel/Seed
$1.2M
Angel/Seed (2016): $1.2M with participation from KES 7 Capital
Key Investors in Damiva
KES 7 Capital
KES 7 Capital Inc. is a hybrid merchant bank that targets bespoke investments for its own capital and that of its partners, including institutions and family offices. The firm maintains a diverse portfolio with specific expertise in healthcare, technology, and energy sectors.
What's next for Damiva?
With the recent strategic investment, Damiva is poised to transition from its early-stage development phase into a more robust scaling operation. The company's roadmap likely involves expanding its distribution channels and broadening its product portfolio to address additional segments within the women's health market. By leveraging this capital, Damiva aims to solidify its market position, potentially exploring new retail partnerships and enhancing its digital presence to reach a wider audience. The focus remains on maintaining the integrity of its natural ingredient supply chain while scaling production to meet the anticipated surge in demand for health-conscious beauty alternatives.
See full Damiva company page
